Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991–1045 (1994).
Article CAS PubMed Google Scholar
Burnet, F. M. The immunological significance of the thymus: an extension of the clonal selection theory of immunity. Australas. Ann. Med. 11, 79–91 (1962).
Article CAS PubMed Google Scholar
Blackman, M., Kappler, J. & Marrack, P. The role of the T cell receptor in positive and negative selection of developing T cells. Science 248, 1335–1341 (1990).
Article CAS PubMed Google Scholar
Kroemer, G. & Martinez, C. The fail–safe paradigm of immunological self-tolerance. Lancet 338, 1246–1249 (1991).
Article CAS PubMed Google Scholar
Vance, R. E. Cutting edge: cutting edge commentary: a Copernican revolution? Doubts about the danger theory. J. Immunol. 165, 1725–1728 (2000).
Article CAS PubMed Google Scholar
Medzhitov, R. & Janeway, C. A. Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296, 298–300 (2002).
Article CAS PubMed Google Scholar
Pradeu, T. & Cooper, E. L. The danger theory: 20 years later. Front. Immunol. 3, 287 (2012).
Article PubMed PubMed Central Google Scholar
Land, W. G. & Messmer, K. The danger theory in view of the injury hypothesis: 20 years later. Front. Immunol. 3, 349 (2012).
Article PubMed PubMed Central Google Scholar
Seong, S. Y. & Matzinger, P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4, 469–478 (2004).
Article CAS PubMed Google Scholar
Matzinger, P. & Kamala, T. Tissue-based class control: the other side of tolerance. Nat. Rev. Immunol. 11, 221–230 (2011).
Article CAS PubMed Google Scholar
Matzinger, P. The danger model: a renewed sense of self. Science 296, 301–305 (2002).
Article CAS PubMed Google Scholar
Gong, T., Liu, L., Jiang, W. & Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 20, 95–112 (2020).
Article CAS PubMed Google Scholar
Carroll, S. L., Pasare, C. & Barton, G. M. Control of adaptive immunity by pattern recognition receptors. Immunity 57, 632–648 (2024).
Article CAS PubMed Google Scholar
Ma, M., Jiang, W. & Zhou, R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity 57, 752–771 (2024).
Article CAS PubMed Google Scholar
Huang, Y., Jiang, W. & Zhou, R. DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways. Nat. Rev. Immunol. 24, 703–719 (2024).
Article CAS PubMed Google Scholar
Lee, M. H. et al. How bile acids and the microbiota interact to shape host immunity. Nat. Rev. Immunol. https://doi.org/10.1038/s41577-024-01057-x (2024).
Remick, B. C., Gaidt, M. M. & Vance, R. E. Effector-triggered immunity. Annu. Rev. Immunol. 41, 453–481 (2023).
Article CAS PubMed Google Scholar
Ma, Y. & Kroemer, G. The cancer-immune dialogue in the context of stress. Nat. Rev. Immunol. 24, 264–281 (2024).
Article CAS PubMed Google Scholar
Tuzlak, S. et al. Repositioning TH cell polarization from single cytokines to complex help. Nat. Immunol. 22, 1210–1217 (2021).
Article CAS PubMed Google Scholar
Ginhoux, F., Guilliams, M. & Merad, M. Expanding dendritic cell nomenclature in the single-cell era. Nat. Rev. Immunol. 22, 67–68 (2022).
Article CAS PubMed Google Scholar
Lazarov, T., Juarez-Carreno, S., Cox, N. & Geissmann, F. Physiology and diseases of tissue-resident macrophages. Nature 618, 698–707 (2023).
Article CAS PubMed PubMed Central Google Scholar
Kroemer, G., Chan, T. A., Eggermont, A. M. M. & Galluzzi, L. Immunosurveillance in clinical cancer management. CA Cancer J. Clin. 74, 187–202 (2024).
Rood, J. E. & Behrens, E. M. Inherited autoinflammatory syndromes. Annu. Rev. Pathol. 17, 227–249 (2022).
Article CAS PubMed Google Scholar
Bousfiha, A. et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J. Clin. Immunol. 42, 1508–1520 (2022).
Akalu, Y. T. & Bogunovic, D. Inborn errors of immunity: an expanding universe of disease and genetic architecture. Nat. Rev. Genet. 25, 184–195 (2024).
Article CAS PubMed Google Scholar
Kepp, O., Marabelle, A., Zitvogel, L. & Kroemer, G. Oncolysis without viruses — inducing systemic anticancer immune responses with local therapies. Nat. Rev. Clin. Oncol. 17, 49–64 (2020).
Article CAS PubMed Google Scholar
Liu, J. et al. Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease. Cancer Discov. 6, 1382–1399 (2016).
Article CAS PubMed Google Scholar
Blank, C. U. et al. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma. Nat. Med. 24, 1655–1661 (2018).
Article CAS PubMed Google Scholar
Patel, S. P. et al. Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N. Engl. J. Med. 388, 813–823 (2023).
Article CAS PubMed PubMed Central Google Scholar
Galluzzi, L., Yamazaki, T. & Kroemer, G. Linking cellular stress responses to systemic homeostasis. Nat. Rev. Mol. Cell Biol. 19, 731–745 (2018).
Article CAS PubMed Google Scholar
Yuan, J. & Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379–395 (2024).
Article CAS PubMed Google Scholar
Medzhitov, R. & Iwasaki, A. Exploring new perspectives in immunology. Cell 187, 2079–2094 (2024).
Article CAS PubMed Google Scholar
Caron, E. et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol. Syst. Biol. 7, 533 (2011).
Comments (0)